Table 3.
Characteristics | Total | SMAD4 expression | P‐value | |
---|---|---|---|---|
High n (%) | Low n (%) | |||
150 | 84 (56.0) | 66 (44.0) | ||
Age (years) | ||||
Median | 62.3 | 66 | 61.7 | |
Range | 19–87 | 47–87 | 19–87 | |
≤65 | 85 | 49 (57.6) | 36 (42.4) | 0.642 |
>65 | 65 | 35 (53.8) | 30 (46.2) | |
Sex | ||||
Male | 76 | 42 (11.7) | 34 (88.3) | 0.854 |
Female | 74 | 42 (19.2) | 32 (80.8) | |
Oral subsite | ||||
Gingiva | 64 | 33 (51.6) | 31 (48.4) | 0.586 |
Tongue | 52 | 25 (48.1) | 27 (51.9) | |
Buccal mucosa | 21 | 14 (66.7) | 7 (33.3) | |
Others | 13 | 12 (92.3) | 1 (0.08) | |
Grade of dysplasia | ||||
None | 101 | 55 (54.5) | 46 (45.5) | 0.859 |
Mild | 37 | 22 (59.5) | 15 (40.5) | |
Moderate, severe | 12 | 7 (58.3) | 5 (41.7) | |
Lymphocyte infiltration | ||||
Low | 51 | 39 (76.5) | 12 (23.5) | 0.00029** |
High | 99 | 45 (45.5) | 54 (54.5) |
The chi‐square test was used to examine the correlation between SMAD4 expression and clinicopathological factors in 150 OL patients.
P < 0.01.